Price T Rowe Associates Inc /Md/

13F Holdings History for QUEST DIAGNOSTICS INC - COMMON STOCK (DGX)

Symbol: DGX on NYSE
Investment type: Equity / COMMON STOCK
Latest Disclosed Ownership: 7.21M shares
Security Ownership: 6.5%

Shares, Excluding Options vs Price

Value, Excluding Options

T. Rowe Price Associates, Inc. ownership in QUEST DIAGNOSTICS INC COMMON STOCK (DGX)

2025-08-14 - T. Rowe Price Associates, Inc. has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 7.21M shares of QUEST DIAGNOSTICS INC COMMON STOCK (DGX). This represents 6.5% percent ownership of the company. In their previous filing dated 2025-05-14, PRICE T ROWE ASSOCIATES INC /MD/ had reported owning 6M shares, indicating an increase of 20.3% percent.

Reporting Name	Ownership %	Change	Value $	Shares owned	Change	Activity %	Price	Form	Report date	Filed at
T. Rowe Price Associates, Inc.	6.5%	+22%	$1.29B	7.21M	+1,214,287	+20.3%	$178.68	13G/A	6/30/2025	14 Aug 2025 13:07:20
T. Rowe Price Associates, Inc.	5.4%		$984M	6M			$164.06	13G	3/31/2025	14 May 2025 10:45:25

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
6/30/2025	0.15%	+0.02%	$1.29B	7.19M	+1,210,459	+20.2%	$179.63	Q2 2025
3/31/2025	0.12%	+0.01%	$1.01B	5.98M	+493,960		$169.20	Q1 2025
12/31/2024	0.1%	+0.03%	$828M	5.49M	+1,637,525	+42.5%	$150.86	Q4 2024
9/30/2024	0.07%	+0.07%	$598M	3.85M	+3,697,500	+2382%	$155.25	Q3 2024
6/30/2024	0%	+0%	$21.3M	155K	+2,869	+1.88%	$136.89	Q2 2024
3/31/2024	0%	-0.04%	$20.3M	152K	-2,451,774	-94.1%	$133.12	Q1 2024
12/31/2023	0.05%	+0.01%	$359M	2.6M	+396,447	+18%	$137.88	Q4 2023
9/30/2023	0.04%	+0.01%	$269M	2.21M	+680,883	+44.6%	$121.86	Q3 2023
6/30/2023	0.03%	+0.03%	$215M	1.53M	+1,376,308	+914%	$140.56	Q2 2023
3/31/2023	0%	-0.02%	$21.3M	151K	-1,136,976	-88.3%	$141.49	Q1 2023
12/31/2022	0.03%	-0.01%	$201M	1.29M	-405,451	-23.9%	$156.44	Q4 2022
9/30/2022	0.03%	+0.01%	$208M	1.69M	+567,417	+50.4%	$122.73	Q3 2022
6/30/2022	0.02%	+0.02%	$150M	1.13M	+952,037	+549%	$132.98	Q2 2022
3/31/2022	0%	0%	$23.7M	173K	-11,297	-6.11%	$136.86	Q1 2022
12/31/2021	0%	0%	$32M	185K	-5,376	-2.83%	$173.01	Q4 2021
9/30/2021	0%	0%	$27.6M	190K	-16,731	-8.09%	$145.31	Q3 2021
6/30/2021	0%	0%	$27.3M	207K	-8,378	-3.89%	$131.97	Q2 2021
3/31/2021	0%	0%	$27.6M	215K	-18,096	-7.75%	$128.34	Q1 2021
12/31/2020	0%	0%	$27.8M	233K	-8,590	-3.55%	$119.17	Q4 2020
9/30/2020	0%	0%	$27.7M	242K	-10,411	-4.13%	$114.49	Q3 2020
6/30/2020	0%	0%	$28.8M	252K	-18,495	-6.83%	$113.96	Q2 2020
3/31/2020	0%	+0%	$21.8M	271K	+21,018	+8.41%	$80.30	Q1 2020
12/31/2019	0%	+0%	$26.7M	250K	+1,302	+0.52%	$106.79	Q4 2019
9/30/2019	0%	0%	$26.6M	249K	-8,153	-3.18%	$107.03	Q3 2019
6/30/2019	0%	+0%	$26.1M	257K	+730	+0.29%	$101.81	Q2 2019
3/31/2019	0%	+0%	$23M	256K	+19,784	+8.38%	$89.92	Q1 2019
12/31/2018	0%	+0%	$19.7M	236K	+6,310	+2.74%	$83.27	Q4 2018
9/30/2018	0%	+0%	$24.8M	230K	+3,574	+1.58%	$107.91	Q3 2018
6/30/2018	0%	0%	$24.9M	226K	-1,250	-0.55%	$109.94	Q2 2018
3/31/2018	0%	0%	$22.8M	228K	-7,120	-3.03%	$100.30	Q1 2018
12/31/2017	0%	0%	$23.1M	235K	-13,790	-5.55%	$98.49	Q4 2017
9/30/2017	0%	0%	$23.3M	248K	-7,468	-2.92%	$93.64	Q3 2017
6/30/2017	0.01%	0%	$28.4M	256K	-30,623	-10.7%	$111.16	Q2 2017
3/31/2017	0.01%	0%	$28.1M	287K	-5,287	-1.81%	$98.19	Q1 2017
12/31/2016	0.01%	0%	$26.8M	292K	-2,240	-0.76%	$91.90	Q4 2016
9/30/2016	0.01%	0%	$24.9M	294K	-6,864	-2.28%	$84.63	Q3 2016
6/30/2016	0.01%	-0.05%	$24.5M	301K	-3,012,930	-90.9%	$81.41	Q2 2016
3/31/2016	0.05%	+0%	$237M	3.31M	+189,868	+6.08%	$71.45	Q1 2016
12/31/2015	0.05%	0%	$222M	3.12M	-8,190	-0.26%	$71.14	Q4 2015
9/30/2015	0.04%	+0%	$193M	3.13M	+79,430	+2.6%	$61.47	Q3 2015
6/30/2015	0.05%	-0.04%	$221M	3.05M	-2,599,650	-46%	$72.52	Q2 2015
3/31/2015	0.09%	-0.03%	$434M	5.65M	-1,876,110	-24.9%	$76.85	Q1 2015
12/31/2014	0.11%	+0.01%	$505M	7.53M	+391,145	+5.48%	$67.06	Q4 2014
9/30/2014	0.09%	+0%	$433M	7.14M	+115,022	+1.64%	$60.68	Q3 2014
6/30/2014	0.09%	-0.01%	$412M	7.02M	-910,131	-11.5%	$58.69	Q2 2014
3/31/2014	0.1%	-0.02%	$459M	7.93M	-1,383,469	-14.9%	$57.92	Q1 2014
12/31/2013	0.11%		$499M	9.32M			$53.54	Q4 2013

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.